Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.23797 | 77 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.17699 | 76 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.2025 | 77 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.79193 | 80 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.24887 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.267 | 78 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.21394 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.30885 | 78 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.28677 | 77 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.47378 | 78 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.31946 | 78 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.21406 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.19496 | 77 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.51446 | 79 |